Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 13 05 2024
revised: 15 06 2024
accepted: 17 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Fatty liver disease has been identified as a marker of malnutrition in different clinical settings. Recently, the COntrolling NUTritional status score (CONUT score) emerged as a promising tool for malnutrition assessment. Our aim was to evaluate short-term outcomes among patients with malnutrition-related liver steatosis in an Internal Medicine department. Furthermore, we evaluated the association of the CONUT score with malnutrition-related liver steatosis. Data from 247 patients hospitalized in an Internal Medicine department were retrospectively collected. The study population was stratified into three groups based on hepatic radiodensity assessed with computed tomography: mild steatosis (≥56.1 HU), moderate steatosis (between 49.7 and 56 HU), and severe steatosis (≤49.6 HU). We then calculated the CONUT score. Severe steatosis patients had higher in-hospital mortality (18.2 vs. 15.5%) and longer in-hospital stays compared with the mild steatosis group (length of in-hospital stay longer than 12 days: 45% vs. 40%). Logistic regression analysis showed that severe steatosis was not significantly associated with in-hospital all-cause death, while a high CONUT score was an independent risk factor for sepsis. We found an independent relationship between malnutrition-associated liver steatosis and the CONUT score. These results identified the CONUT score as a tool for nutritional assessment of hospitalized patients.

Identifiants

pubmed: 38931279
pii: nu16121925
doi: 10.3390/nu16121925
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Nicoletta Miano (N)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Giorgia Todaro (G)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Maurizio Di Marco (M)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Sabrina Scilletta (S)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Giosiana Bosco (G)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Francesco Di Giacomo Barbagallo (F)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Roberto Scicali (R)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Salvatore Piro (S)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Francesco Purrello (F)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Antonino Di Pino (A)

Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH